Legacy Financial Strategies LLC Sells 2,742 Shares of Aflac Incorporated (NYSE:AFL)

Legacy Financial Strategies LLC lowered its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 7.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,343 shares of the financial services provider's stock after selling 2,742 shares during the period. Aflac makes up 0.9% of Legacy Financial Strategies LLC's investment portfolio, making the stock its 18th largest position. Legacy Financial Strategies LLC's holdings in Aflac were worth $4,041,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of AFL. Whipplewood Advisors LLC purchased a new position in shares of Aflac during the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new position in Aflac in the 4th quarter worth approximately $34,000. Curio Wealth LLC purchased a new position in Aflac in the 4th quarter worth approximately $36,000. Capital A Wealth Management LLC purchased a new position in Aflac in the 4th quarter worth approximately $38,000. Finally, OFI Invest Asset Management purchased a new position in Aflac in the 4th quarter worth approximately $38,000. 67.44% of the stock is currently owned by institutional investors.

Aflac Stock Up 0.2%

Shares of NYSE AFL traded up $0.24 during mid-day trading on Monday, hitting $103.78. 1,809,853 shares of the stock traded hands, compared to its average volume of 2,111,452. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a 52 week low of $86.46 and a 52 week high of $115.50. The company has a market cap of $56.11 billion, a price-to-earnings ratio of 10.81, a PEG ratio of 3.24 and a beta of 0.84. The stock has a fifty day moving average price of $106.15 and a 200-day moving average price of $106.15.

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a return on equity of 16.20% and a net margin of 28.76%. The company had revenue of $3.40 billion during the quarter, compared to the consensus estimate of $4.53 billion. During the same period last year, the firm posted $1.66 earnings per share. The company's revenue was down 37.5% compared to the same quarter last year. Research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st will be paid a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.24%. The ex-dividend date is Wednesday, May 21st. Aflac's dividend payout ratio is currently 36.25%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AFL. Keefe, Bruyette & Woods lifted their price target on Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research note on Wednesday, May 7th. Barclays lifted their price target on Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a research note on Thursday, May 1st. Wall Street Zen cut Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Morgan Stanley lifted their price target on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Monday, May 19th. Finally, UBS Group lifted their price objective on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, Aflac presently has a consensus rating of "Hold" and a consensus target price of $104.93.

Insider Transactions at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the sale, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This represents a 3.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the company's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the sale, the director now owns 70,992 shares of the company's stock, valued at approximately $7,496,045.28. The trade was a 34.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 71,552 shares of company stock worth $7,609,382 over the last quarter. 0.90% of the stock is currently owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.